PT - JOURNAL ARTICLE AU - Luo, Dingcun AU - Ni, Yeqin AU - Zhang, Shirong AU - Xun, Yanping AU - Zhao, Pan AU - Wu, Fan AU - Zhou, Tianhan AU - Shi, Jingjing AU - Lu, Si AU - Sun, Sihan AU - Lu, Kaining TI - The ratio of BRAFV600E alleles can be used to assess the biological behavior of papillary thyroid carcinoma AID - 10.1101/2020.10.31.20223610 DP - 2020 Jan 01 TA - medRxiv PG - 2020.10.31.20223610 4099 - http://medrxiv.org/content/early/2020/11/04/2020.10.31.20223610.short 4100 - http://medrxiv.org/content/early/2020/11/04/2020.10.31.20223610.full AB - Background The BRAFV600E mutations is an important molecular event in the occurrence and development of papillary thyroid carcinoma (PTC). A qualitative detection of the BRAFV600E mutation is still insufficient to explain the biological behavior of PTC. Though quantitative detection of the BRAFV600E mutation can reflect certain characteristics of PTC, its clinical value is still controversial. We aimed to investigate the association between the ratio of BRAFV600E alleles and clinicopathological parameters in PTC patients.Methods Genomic DNA was extracted from specimens obtained from 329 PTC patients undergoing thyroidectomy. The ratio of BRAFV600E alleles was determined by amplification refractory mutation system (ARMS) and droplet digital polymerase chain reaction (ddPCR). Inconsistent results were further verified by next-generation sequencing (NGS). The clinicopathologic features, clinical tumor stage, and tumor recurrence risk stratification of all patients were correlated with the ratio of BRAFV600E alleles.Results The sensitivity of ddPCR was superior to that of ARMS and almost the same as that of NGS. In total, 275 of 329 patients had the BRAFV600E mutation as determined by ARMS, ddPCR and NGS. The ratio of BRAFV600E alleles ranged from 0.17%-48.0%, with a median ratio of 12.58%, and significantly correlated with tumor size (p<0.001), capsule or extrathyroidal invasion (p<0.001), the number or rate of lymph node metastases (p<0.001), tumor stage (p=0.006) and tumor recurrence risk (p<0.001) but not with sex, age or multifocality. The ratio of BRAFV600E alleles was much lower in PTC patients with Hashimoto’s thyroiditis than in those without (p<0.001).Conclusions The ratio of BRAFV600E alleles can reliably reflect the biological behavior of PTC, making it a molecular-based stratification index of recurrence risk. The quantitative detection of BRAFV600E has the potential to guide the clinical diagnosis and treatment of PTC.Competing Interest StatementThe authors have declared no competing interest.Funding StatementThis work was supported by grant from the Key Project of Scientific and Technological Innovation in Hangzhou (award number: 20131813A08) and the Medical Science Research Program of Hangzhou (award number: OO20190490).Author DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:All the cases were obtained with informed consent. The research was approved by the Ethics Committee of Affiliated Hangzhou First People Hospital, Zhejiang University School of Medicine.All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesData that support the findings of this report are available from the corresponding author upon request.